NCT00017524View on ClinicalTrials.gov

AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

November 30, 2004

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pelitrexol

Trial Locations (3)

85724

Arizona Cancer Center, Tucson

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00017524 - AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter